Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pericarditis I: Introduction01:22

Pericarditis I: Introduction

57
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
57
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

70
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
70
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

63
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
63
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

33
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
33
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

110
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
110
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

49
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
49

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liver fibrosis and steatosis in psoriatic arthritis: a real-world elastography-based study.

Joint bone spine·2026
Same author

Validation of screening criteria for interstitial lung disease in rheumatoid arthritis in routine clinical practice: the VAR-EPIDSER study.

RMD open·2026
Same author

Response of ultrasound-assessed synovitis to baricitinib, in monotherapy and combined with methotrexate, compared with etanercept in rheumatoid arthritis: a randomised, international, multicentre trial.

Annals of the rheumatic diseases·2026
Same author

Health Outcomes in Fragility Fractures in the Spanish Registry of Osteoporotic Fractures According to the FLS Care Model.

Archives of medical research·2025
Same author

Evaluation of serum IgG4 levels as a screening tool for IgG4-related disease: Data from a retrospective study.

Reumatologia clinica·2025
Same author

Gender differences in clinical and prescribing characteristics of biologic and targeted synthetic drugs in naïve patients with rheumatoid arthritis: Data from BIOBADASER III registry.

Arthritis research & therapy·2025

Related Experiment Video

Updated: Oct 23, 2025

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

2.7K

Recurrent Pericarditis After Covid-19.

David Rodrigo Domínguez1, Amalia Rueda Cid2, Cristina Campos Fernández2

  • 1Servicio de Medicina Interna, Consorcio Hospital General Universitario de Valencia, Valencia, España.

Reumatologia Clinica
|August 21, 2021
PubMed
Summary

This case study discusses a rheumatoid arthritis patient experiencing recurrent pericarditis as their initial symptom of COVID-19. It highlights the importance of considering COVID-19 in the differential diagnosis for such presentations.

Keywords:
Artritis reumatoideBiological treatmentCOVID-19PericarditisRheumatoid arthritisTratamiento biológico

More Related Videos

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.4K
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

2.8K

Related Experiment Videos

Last Updated: Oct 23, 2025

An Intact Pericardium Ischemic Rodent Model
07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

2.7K
Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
08:05

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia

Published on: December 19, 2020

14.4K
Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

2.8K

Area of Science:

  • Rheumatology
  • Infectious Diseases
  • Cardiology

Background:

  • Rheumatoid arthritis (RA) is a chronic autoimmune disease.
  • COVID-19 can present with diverse and atypical symptoms.
  • Recurrent pericarditis is an inflammatory condition of the pericardium.

Observation:

  • A patient with a known diagnosis of rheumatoid arthritis presented with recurrent pericarditis.
  • The onset of recurrent pericarditis coincided with a COVID-19 infection.
  • This presentation was the initial manifestation of COVID-19 for the patient.

Findings:

  • The study identifies a potential link between COVID-19 infection and the debut of recurrent pericarditis in an RA patient.
  • Differential diagnosis for recurrent pericarditis must include infectious etiologies like COVID-19, especially in immunocompromised individuals.
  • This case underscores the varied clinical spectrum of SARS-CoV-2 infection.

Implications:

  • Highlights the need for heightened clinical suspicion for COVID-19 in RA patients presenting with pericarditis.
  • Suggests that SARS-CoV-2 could be an underrecognized trigger for pericarditis, particularly in autoimmune disease populations.
  • Informs diagnostic strategies and patient management in rheumatology and infectious disease settings.